Back to Search
Start Over
Oral treatment with enrofloxacin creates anti-inflammatory environment that supports induction of tolerogenic dendritic cells.
- Source :
-
International immunopharmacology [Int Immunopharmacol] 2019 Dec; Vol. 77, pp. 105966. Date of Electronic Publication: 2019 Oct 31. - Publication Year :
- 2019
-
Abstract
- Background: Oral enrofloxacin treatment altered the gut microbiome promoting anti-inflammatory bacteria. The dysbiosis promotes regulatory cell induction in the intestines and in the periphery, which suppresses contact sensitivity. Bacterial-derived signals promote regulatory cell induction both directly and indirectly by influencing the phenotype of dendritic cells (DC).<br />Methods: Oral treatment with broad-spectrum antibiotic enrofloxacin was used to evaluate how gut flora perturbation shapes the immune response in the gut and the periphery.<br />Results: Enrofloxacin-induced dysbiosis creates an anti-inflammatory environment characterized by increased IL-10 concentration in the gut lumen and tissues. The production of IFN-γ and IL-17A did not change. Oral enrofloxacin treatment skewed the profile of the immune response towards an anti-inflammatory phenotype locally in small intestinal Peyer's Patches (PP) and systematically in the spleen (SPL). Enrofloxacin administration changed immune response in PP by increasing TGF-β secretion from an increased percentage of TGF-β-producing. In the SPL, enrofloxacin treatment increased the secretion of TGF-β and IL-10 and decreased the secretion of IL-17A and IFN-γ. The shift in cytokine profile correlated with a higher percentage of latency-associated peptide and IL-10-producing cells and a decreased percentage of IFN-γ-producing T cells. This anti-inflammatory immune response in the PP and SPL promoted a higher frequency of tolerogenic DC.<br />Conclusion: Our data indicate that two-week enrofloxacin treatment induces dysbiosis, skews immune response towards an anti-inflammatory phenotype, and elevates secretion of TGF-β and IL-10 in the intestines and periphery. Additionally, we observed higher frequencies of tolerogenic DC, characterized by CD11b and IL-10 expression, which are known inducers of Treg cells.<br /> (Copyright © 2019 Elsevier B.V. All rights reserved.)
- Subjects :
- Administration, Oral
Animals
Dendritic Cells metabolism
Gastrointestinal Microbiome drug effects
Interferon-gamma metabolism
Interleukin-10 metabolism
Interleukin-17 metabolism
Mice
Mice, Inbred C57BL
Peyer's Patches metabolism
Spleen drug effects
Spleen metabolism
T-Lymphocytes, Regulatory drug effects
T-Lymphocytes, Regulatory metabolism
Transforming Growth Factor beta metabolism
Anti-Inflammatory Agents pharmacology
Dendritic Cells drug effects
Enrofloxacin pharmacology
Immune Tolerance drug effects
Subjects
Details
- Language :
- English
- ISSN :
- 1878-1705
- Volume :
- 77
- Database :
- MEDLINE
- Journal :
- International immunopharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 31679846
- Full Text :
- https://doi.org/10.1016/j.intimp.2019.105966